Alumis' lupus drug fails mid-stage trial goal
01/09/2026 12:34
Alumis' lupus drug fails mid-stage trial goal Sept 1 (Reuters) - Alumis ALMS.O said on Tuesday its experimental drug failed to meet the main goal of a mid-stage trial in patients with a chronic autoimmune disease called systemic lupus erythematosus.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Leroy Leo)
Recent news on Alumis
See all newsBrief: Alumis Says Envudeucitinib Improves Psoriasis Symptoms in Phase 3 Data
U.S. RESEARCH ROUNDUP-Adobe, Dell Technologies, Zscaler
Alumis set for worst day after lupus drug misses main goal in mid-stage trial
Alumis eyes late-stage lupus study despite trial miss (updated)
Alumis tumbles after lupus drug misses main goal in mid-stage trial